// AST – IMS - [DMinute_ROS]

Trust Co Of Vermont Position in Pfizer (PFE) Has Boosted by $484,380 as Market Valuation Rose; Bangor Savings Bank Raised Stake in Enbridge (ENB) by $567,665

Pfizer Inc. (NYSE:PFE) Logo

Bangor Savings Bank increased its stake in Enbridge Incorporated (ENB) by 33.12% based on its latest 2018Q2 regulatory filing with the SEC. Bangor Savings Bank bought 16,219 shares as the company’s stock rose 5.40% with the market. The institutional investor held 65,185 shares of the natural gas distribution company at the end of 2018Q2, valued at $2.33M, up from 48,966 at the end of the previous reported quarter. Bangor Savings Bank who had been investing in Enbridge Incorporated for a number of months, seems to be bullish on the $59.28B market cap company. The stock decreased 1.64% or $0.54 during the last trading session, reaching $32.32. About 8.55M shares traded or 104.69% up from the average. Enbridge Inc. (NYSE:ENB) has declined 16.60% since December 7, 2017 and is downtrending. It has underperformed by 32.22% the S&P500. Some Historical ENB News: 09/05/2018 – ENBRIDGE INC – DEAL WILL ALSO ELIMINATE $500 MLN OF EQUITY CAPITAL REQUIREMENT PREVIOUSLY INCLUDED IN FUNDING PLAN; 16/04/2018 – Michigan PSC: Straits investigation continues with anticipated launch of underwater vehicles to inspect ATC, Enbridge lines; 09/05/2018 – Enbridge Cuts Spectra Deal Debt With $2.5 Billion in Asset Sales; 10/05/2018 – ENBRIDGE CONCLUDES FIRST-QUARTER EARNINGS CONFERENCE CALL; 16/03/2018 – ENBRIDGE INC – SEP ANTICIPATES NO IMPACT IS EXPECTED TO ITS PREVIOUSLY PROVIDED 2018 FINANCIAL GUIDANCE; 16/03/2018 – ENBRIDGE – NEW FERC POLICY TO CAUSE A FURTHER DECREASE TO DISTRIBUTABLE CASH FLOW FOR EEP OF ABOUT $80 MLN ON ANNUAL BASIS; 05/04/2018 – ENBRIDGE IS SAID TO SEEK PARTIAL SALE OF GERMAN WIND FARM STAKE; 18/05/2018 – Enbridge Energy Partners Acknowledges Enbridge Inc. Offer and Establishes a Special Committee; 18/05/2018 – ENBRIDGE’S STINGRAY: CONTINUED ONSHORE COMPRESSION OUTAGE; 23/03/2018 – Michigan PSC: MDEQ issues Enbridge a permit for 22 anchors in Straits

Trust Co Of Vermont increased its stake in Pfizer Inc (PFE) by 5% based on its latest 2018Q2 regulatory filing with the SEC. Trust Co Of Vermont bought 13,455 shares as the company’s stock rose 17.09% with the market. The institutional investor held 282,695 shares of the health care company at the end of 2018Q2, valued at $10.26M, up from 269,240 at the end of the previous reported quarter. Trust Co Of Vermont who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $260.01B market cap company. The stock decreased 0.35% or $0.16 during the last trading session, reaching $44.98. About 30.54M shares traded or 36.20% up from the average. Pfizer Inc. (NYSE:PFE) has risen 19.90% since December 7, 2017 and is uptrending. It has outperformed by 4.28% the S&P500. Some Historical PFE News: 01/05/2018 – PFIZER 1Q ADJ EPS 77C, EST. 75C; 10/04/2018 – Pfizer heads to the Hudson, signs 20-year lease at posh new NYC headquarters $PFE @BrittanyMeiling; 23/03/2018 – Pfizer’s Smoking-Cessation Pill Chantix Fails in Adolescent Study; 01/05/2018 – PFIZER FIRST QUARTER EARNINGS CALL BEGINS; 23/04/2018 – Pfizer: FDA Highlights Need for Additional Technical Info; 11/05/2018 – eFFECTOR Initiates Randomized Dosing in Phase 2 Checkpoint Combination Trial of eFT508 and Avelumab in Colorectal Cancer; 11/03/2018 – PFIZER, BMY SAY ELIQUIS USE ASSOCIATED W/ LOWER RATES OF STROKE; 10/04/2018 – New York Post: Pfizer moving headquarters to Hudson Yards; 21/05/2018 – KARO PHARMA GETS MILESTONE PAYMENT FROM PFIZER; 25/04/2018 – ASTELLAS PHARMA FY XTANDI SALES 294.3B YEN

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Fool.com which released: “Better Buy: Pfizer vs. Bristol-Myers Squibb – The Motley Fool” on November 25, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Announces FDA Approval of DAURISMO – StreetInsider.com” published on November 21, 2018, Seekingalpha.com published: “Pfizer’s Rituxan biosimilar successful in late-stage study; shares up 1% premarket – Seeking Alpha” on December 03, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Why Pfizer Is Up 19% in 2018 So Far – Motley Fool” published on November 15, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer Inc. (PFE) Management Presents on Evercore ISI HealthCONx Conference Call Transcript – Seeking Alpha” with publication date: November 28, 2018.

Trust Co Of Vermont, which manages about $1.12 billion US Long portfolio, decreased its stake in Pg&E Corp (NYSE:PCG) by 8,624 shares to 1,333 shares, valued at $57,000 in 2018Q2, according to the filing.

Since June 6, 2018, it had 0 insider buys, and 2 selling transactions for $1.92 million activity. Shares for $418,774 were sold by OLSON LAURIE J on Monday, August 13.

Investors sentiment decreased to 0.78 in Q2 2018. Its down 0.11, from 0.89 in 2018Q1. It is negative, as 52 investors sold PFE shares while 754 reduced holdings. 112 funds opened positions while 518 raised stakes. 3.98 billion shares or 0.73% less from 4.01 billion shares in 2018Q1 were reported. Amp Capital Invsts holds 0.4% of its portfolio in Pfizer Inc. (NYSE:PFE) for 1.98M shares. Meyer Handelman holds 1.59M shares or 2.95% of its portfolio. Cap International Invsts reported 31.57 million shares. Gateway Advisory Ltd Co has invested 0.06% in Pfizer Inc. (NYSE:PFE). Dakota Wealth Management has 43,153 shares. Veritas Asset Limited Liability Partnership owns 0.42% invested in Pfizer Inc. (NYSE:PFE) for 1.41M shares. Tokio Marine Asset Mgmt Com Ltd reported 0.48% of its portfolio in Pfizer Inc. (NYSE:PFE). Chilton Cap Mngmt Lc holds 22,663 shares or 0.08% of its portfolio. World stated it has 37.83M shares. Capstone Advisors Incorporated reported 0.08% in Pfizer Inc. (NYSE:PFE). Frontier Inv reported 0.09% of its portfolio in Pfizer Inc. (NYSE:PFE). Summit Financial Wealth Advsrs Ltd Liability Company reported 96,491 shares. Mariner Wealth Advsrs invested in 177,103 shares. North Carolina-based Altavista Wealth Mngmt has invested 1.11% in Pfizer Inc. (NYSE:PFE). Rothschild Asset Mgmt reported 2.32M shares or 0.9% of all its holdings.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 88 analyst reports since July 29, 2015 according to SRatingsIntel. Morgan Stanley maintained the shares of PFE in report on Wednesday, January 31 with “Overweight” rating. The rating was maintained by Piper Jaffray on Thursday, September 14 with “Buy”. The firm earned “Neutral” rating on Wednesday, October 31 by Credit Suisse. Jefferies maintained it with “Buy” rating and $39 target in Thursday, April 7 report. The company was maintained on Monday, August 14 by Cowen & Co. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, June 7. The rating was downgraded by Credit Suisse to “Neutral” on Thursday, July 20. As per Thursday, April 7, the company rating was reinitiated by JP Morgan. The firm has “Market Perform” rating by Leerink Swann given on Wednesday, January 31. On Friday, April 28 the stock rating was maintained by BMO Capital Markets with “Hold”.

Among 17 analysts covering Enbridge Inc. (NYSE:ENB), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Enbridge Inc. had 31 analyst reports since August 4, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Equal-Weight” rating and $38 target in Friday, February 9 report. The stock of Enbridge Inc. (NYSE:ENB) has “Equal-Weight” rating given on Friday, July 13 by Morgan Stanley. BMO Capital Markets initiated the stock with “Outperform” rating in Friday, October 23 report. The rating was upgraded by Wells Fargo on Tuesday, November 6 to “Outperform”. The rating was downgraded by Goldman Sachs on Wednesday, July 20 to “Neutral”. JP Morgan reinitiated Enbridge Inc. (NYSE:ENB) on Friday, June 23 with “Neutral” rating. Citigroup reinitiated the stock with “Neutral” rating in Wednesday, January 18 report. As per Monday, May 15, the company rating was maintained by Wolfe Research. Morgan Stanley maintained Enbridge Inc. (NYSE:ENB) rating on Friday, November 17. Morgan Stanley has “Equal-Weight” rating and $41 target. The rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, March 23.

More notable recent Enbridge Inc. (NYSE:ENB) news were published by: Seekingalpha.com which released: “Enbridge pushes back on claim ‘air barrels’ sent through Mainline system – Seeking Alpha” on November 21, 2018, also Fool.ca with their article: “Is Enbridge’s (TSX:ENB) (USA) Dividend Safe? – The Motley Fool Canada” published on November 18, 2018, Fool.ca published: “Oil, the Loonie and What Happens Next – The Motley Fool Canada” on November 28, 2018. More interesting news about Enbridge Inc. (NYSE:ENB) were released by: Fool.ca and their article: “These Top 2 Income Plays Grew Their Dividends by 15%+ Annually Over the Past 10 Years – The Motley Fool Canada” published on December 04, 2018 as well as Nasdaq.com‘s news article titled: “Why Enbridge Belongs In Your Long-Term Portfolio – Nasdaq” with publication date: December 06, 2018.

Bangor Savings Bank, which manages about $517.77M US Long portfolio, decreased its stake in Intercontinental Exchange Inc (NYSE:ICE) by 4,854 shares to 27,981 shares, valued at $2.06M in 2018Q2, according to the filing. It also reduced its holding in Ishares Iboxx Usd High Yield (HYG) by 5,176 shares in the quarter, leaving it with 8,158 shares, and cut its stake in Qualcomm Inc (NASDAQ:QCOM).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.